Free Access
J Extra Corpor Technol
Volume 46, Number 4, December 2014
Page(s) 310 - 313
Published online 15 December 2014
  1. John R, Liao K, Lietz K, et al. Experience with the Levitronix CentriMag circulatory support system as a bridge to decision in patients with refractory acute cardiogenic shock and multisystem organ failure. J Thorac Cardiovasc Surg. 2007;134:351–358. [CrossRef] [Google Scholar]
  2. Shuhaiber JH, Jenkins D, Berman M, et al. The Papworth experience with the Levitronix CentriMag ventricular assist device. J Heart Lung Transplant. 2008;27:158–164. [CrossRef] [Google Scholar]
  3. Loforte A, Montalto A, Ranocchi F, et al. Levitronix CentriMag third-generation magnetically levitated continuous flow pump as bridge to solution. ASAIO J. 2011;57:247–253. [CrossRef] [PubMed] [Google Scholar]
  4. John R, Long JW, Massey HT, et al. Outcomes of a multicenter trial of the Levitronix CentriMag ventricular assist system for short-term circulatory support. J Thorac Cardiovasc Surg. 2011;141:932–939. [CrossRef] [Google Scholar]
  5. Worku B, Pak S-W, van Patten D, et al. The CentriMag ventricular assist device in acute heart failure refractory to medical management. J Heart Lung Transplant. 2012;31:611–617. [CrossRef] [Google Scholar]
  6. Takayama H, Soni L, Kalesan B, et al. Bridge-to-decision therapy with a continuous-flow external ventricular assist device in refractory cardiogenic shock of various etiologies. Circ Heart Fail. 2014;7:799–800. [CrossRef] [PubMed] [Google Scholar]
  7. Slaughter MS, Rogers JG, Milano CA, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361:2241–2251. [CrossRef] [PubMed] [Google Scholar]
  8. Takayama H, Chen JM, Jorde UP, Naka Y. Implantation technique of the CentriMag biventricular assist device allowing ambulatory rehabilitation. Interact Cardiovasc Thorac Surg. 2011;12:110–111. [CrossRef] [PubMed] [Google Scholar]
  9. Eckman PM, John R. Bleeding and thrombosis in patients with continuous-flow ventricular assist devices. Circulation. 2012;125:3038–3047. [CrossRef] [PubMed] [Google Scholar]
  10. Rothenburger M, Wilhelm MJ, Hammel D, et al. Treatment of thrombus formation associated with the MicroMed DeBakey VAD using recombinant tissue plasminogen activator. Circulation. 2002;106(Suppl 1):I189–92. [CrossRef] [PubMed] [Google Scholar]
  11. Tang GHL, Kim MC, Pinney SP, Anyanwu AC. Failed repeated thrombolysis requiring left ventricular assist device pump exchange. Catheter Cardiovasc Interv. 2013;81:1072–1074. [CrossRef] [Google Scholar]
  12. Young G, Yonekawa KE, Nakagawa PA, Blain RC, Lovejoy AE, Nugent DJ. Differential effects of direct thrombin inhibitors and antithrombin-dependent anticoagulants on the dynamics of clot formation. Blood Coagul Fibrinolysis. 2007;18:97–103. [CrossRef] [PubMed] [Google Scholar]
  13. Raaz U, Kaeberich A, Maegdefessel L, et al. The direct thrombin inhibitor argatroban effectively prevents cardiac catheter thrombosis in vitro. Thromb Haemost. 2010;103:808–814. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.